A Study to Compare the Efficacy and Safety of SCENESSE and Narrow-Band Ultraviolet (NB-UVB) Light Versus NB-UVB Light Alone in Patients With Vitiligo

Exclusion Criteria

• •Fitzpatrick skin types I-II
• •Extensive leukotrichia
• •Treatment with NB-UVB phototherapy in the last three months prior to study start
• •Allergy to afamelanotide or the polymer contained in the implant
• •Any other treatment for vitiligo within 30 days prior to the Screening Visit
• •History of melanoma or lentigo maligna
• •History of dysplastic nevus syndrome
• •Any malignant skin lesions
• •Presence of severe hepatic disease or hepatic impairment
• •Female who is pregnant or lactating
• •Female of child-bearing potential not using adequate contraceptive measures
• •Sexually active man with a partner of child-bearing potential who is not using adequate contraceptive measures
• •Use of any prior and concomitant therapy which may interfere with the objective of the study
• •Extensive tattoos